Our continuing vision for the Molecular Imaging Program at Stanford (MIPS) has been to bring molecular imaging technolo-gies to basic science cancer researchers – to create an environ-ment in which non-invasive imaging technologies that permit longitudinal studies of tumor initiation, progression, metastasis and response to therapy would be adopted by basic scientists studying cancer. Within the MIPS program, we continue to develop animal models of cancer in which molecular imag-ing adds new dimensions to experimental design and allows investigators to acquire time-dependent data that could not be obtained in any other way. The MIPS program is supported by numerous funding sources, including the National Institutes of Health, multiple foundations, and strong industry partnerships. Since the inception of MIPS (2003), we have followed a clearly defined roadmap toward translating our work into clinical use to benefit patients.

Photo of Dr. Gambhir speaking at 2012 TedXStanford

Dr. Gambhir's TedXStanford lecture
"Molecular Spies for Early Disease Detection"

News & Events

Recent News

Dr. Airan is the Finalist for the Science-PINS Prize for Neuromodulation

August 4, 2017

Dr. Daldrup-Link Appointed to Join the Radiology Leadership Team

August 1, 2017

Farewell Peter Kezheng Wang & Lingbo Mable Zhang

July 18, 2017

Stanford launches Project Baseline study by enrolling first participant

July 17, 2017

Hao Chen Received SNMMI - CMIIT 2017 Young Investigator Award

June 22, 2017

Farewell Dr.'s Ferrara, He, and Lee

June 20, 2017

Winners of the Catalyst for Collaborative Solutions Announced and MIPS is Included

June 12, 2017